Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1992-2-18
|
pubmed:abstractText |
Seventeen infants less than 1 year of age have undergone heart (12), heart-lung (3), and lung (2) transplantation for end-stage cardiopulmonary disease. The infants undergoing heart transplantation had a mean age of 4.5 months (range, 19 days to 12 months) with the diagnosis of cardiomyopathy in 4 and congenital heart disease in 8. Four of the 8 patients (50%) had hypoplastic left heart syndrome. Actuarial survival at 1 and 2 years was 74% and compared favorably with the survival of older children at 1 and 2 years of 82% and 69%. The linearized rejection rate was less in infants as compared with children more than 1 year of age (0.61 versus 1.48 episodes per 100 patient days). In intermediate follow-up, no graft atherosclerosis has been noted. Immunosuppression has included a three-drug protocol of cyclosporine, azathioprine, and prednisone. A steroid taper to alternate day steroids or off completely by 6 months has been the goal and has been accomplished in 6 of 12 infants. Heart-lung and lung transplantation has been performed in 5 infants. One infant in each group died: 1 infant secondary to airway complications and sepsis and another due to pulmonary sepsis. A pulmonary lobe from a larger and older donor was transplanted into a 4-week-old infant as a single-lung transplant with good outcome. The 3 surviving infants are well 24, 18, and 2 months after transplantation. Obliterative bronchiolitis has not been clinically apparent in this group. These data support the clinical efficacy of heart, heart-lung, and lung transplantation in the first year of life.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0003-4975
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
306-10
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1731673-Actuarial Analysis,
pubmed-meshheading:1731673-Cause of Death,
pubmed-meshheading:1731673-Cyclosporine,
pubmed-meshheading:1731673-Female,
pubmed-meshheading:1731673-Follow-Up Studies,
pubmed-meshheading:1731673-Graft Rejection,
pubmed-meshheading:1731673-Heart Defects, Congenital,
pubmed-meshheading:1731673-Heart Diseases,
pubmed-meshheading:1731673-Heart Transplantation,
pubmed-meshheading:1731673-Heart-Lung Transplantation,
pubmed-meshheading:1731673-Humans,
pubmed-meshheading:1731673-Infant,
pubmed-meshheading:1731673-Infant, Newborn,
pubmed-meshheading:1731673-Lung Transplantation,
pubmed-meshheading:1731673-Male,
pubmed-meshheading:1731673-Postoperative Complications
|
pubmed:year |
1992
|
pubmed:articleTitle |
Heart, heart-lung, and lung transplantation in the first year of life.
|
pubmed:affiliation |
Department of Cardiothoracic Surgery, Stanford University Medical Center, California 94305.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.
|